Request Deal Involvement

Enavate Sciences and Venrock Healthcare led a $200m Series B funding round in Upstream Bio.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

MacDougall

pr advisors

MacDougall

Cooley

legal advisors

Cooley

or

Principals

ALTSHULER SHAHAM

bidder

ALTSHULER SHAHAM

UPSTREAM BIO

target

UPSTREAM BIO

ACCESS BIOTECHNOLOGY

bidder

ACCESS BIOTECHNOLOGY

ENAVATE SCIENCES

bidder

ENAVATE SCIENCES

VENROCK HEALTHCARE CAPITAL PARTNERS

bidder

VENROCK HEALTHCARE CAPITAL PARTNERS

BAIN CAPITAL LIFE SCIENCES

bidder

BAIN CAPITAL LIFE SCIENCES

WELLINGTON MANAGEMENT

bidder

WELLINGTON MANAGEMENT

ORBIMED ADVISORS LLC

bidder

ORBIMED ADVISORS LLC

DECHENG CAPITAL LLC

bidder

DECHENG CAPITAL LLC

TCG X

bidder

TCG X

HBM HEALTHCARE INVESTMENTS

bidder

HBM HEALTHCARE INVESTMENTS

OMEGA FUNDS

bidder

OMEGA FUNDS

SAMSARA BIOCAPITAL

bidder

SAMSARA BIOCAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite